Ganguly; Ashit K.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ganguly; Ashit K..The latest application filed is for "febrifugine derivatives".

Company Profile

0.38.14

Ganguly; Ashit K. - Belmont MA
Ganguly; Ashit K. - Upper Montclair NJ
Ganguly, Ashit K. - Upper Mountclair NJ
Ganguly; Ashit K. - Montclair NJ
Ganguly; Ashit K. - Upper Monclair NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Febrifugine Derivatives App 20210163443 - Shirude; Pravin Sudhakar ; et al.	2021-06-03
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant RE43,298 - Saksena , et al. April 3, 2	2012-04-03
Novel Peptides As Ns3-serine Protease Inhibitors Of Hepatitis C Virus App 20110117057 - Saksena; Anil K. ; et al.	2011-05-19
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 7,595,299 - Saksena , et al. September 29, 2	2009-09-29
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 7,244,721 - Saksena , et al. July 17, 2	2007-07-17
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20070032433 - Saksena; Anil K. ; et al.	2007-02-08
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 7,169,760 - Saksena , et al. January 30, 2	2007-01-30
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection Grant 7,115,578 - Ganguly , et al. October 3, 2	2006-10-03
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20060205672 - Saksena; Anil K. ; et al.	2006-09-14
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 7,012,066 - Saksena , et al. March 14, 2	2006-03-14
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20050176648 - Saksena, Anil K. ; et al.	2005-08-11
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection Grant 6,924,270 - Ganguly , et al. August 2, 2	2005-08-02
Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties Grant 6,914,122 - Venkatraman , et al. July 5, 2	2005-07-05
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20050059606 - Saksena, Anil K. ; et al.	2005-03-17
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection App 20050004053 - Ganguly, Ashit K. ; et al.	2005-01-06
Imidazolidinones as NS3-serine protease inhibitors of hepatitis C virus Grant 6,838,475 - Arasappan , et al. January 4, 2	2005-01-04
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20040254117 - Saksena, Anil K. ; et al.	2004-12-16
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 6,800,434 - Saksena , et al. October 5, 2	2004-10-05
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection Grant 6,673,775 - Ganguly , et al. January 6, 2	2004-01-06
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20030216325 - Saksena, Anil K. ; et al.	2003-11-20
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20030036501 - Saksena, Anil K. ; et al.	2003-02-20
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection App 20030004119 - Ganguly, Ashit K. ; et al.	2003-01-02
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20020160962 - Saksena, Anil K. ; et al.	2002-10-31
Novel imidazolidinones as NS3-serine protease inhibitors of hepatitis C virus App 20020102235 - Arasappan, Ashok ; et al.	2002-08-01
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection Grant 6,403,564 - Ganguly , et al. June 11, 2	2002-06-11
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection App 20020055473 - Ganguly, Ashit K. ; et al.	2002-05-09
5'-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon Grant 6,277,830 - Ganguly , et al. August 21, 2	2001-08-21
Pharmaceutically active compounds Grant 5,750,532 - Girijavallabhan , et al. May 12, 1	1998-05-12
Tetrahydrofuran antifungals Grant 5,714,490 - Saksena , et al. February 3, 1	1998-02-03
Tetrahydrofuran antifungals Grant 5,710,154 - Saksena , et al. January 20, 1	1998-01-20
Tetrahydrofuran antifungals Grant 5,693,626 - Saksena , et al. December 2, 1	1997-12-02
Tetrahydrofuran antifungals Grant 5,661,151 - Saksena , et al. August 26, 1	1997-08-26
Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring Grant 5,463,074 - Shih , et al. October 31, 1	1995-10-31
Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives Grant 5,439,916 - Ganguly , et al. August 8, 1	1995-08-08
Process for preparing intermediates for the synthesis of antifungal agents Grant 5,403,937 - Saksena , et al. April 4, 1	1995-04-04
Pharmaceutically active compounds Grant 5,272,167 - Girijavallabhan , et al. December 21, 1	1993-12-21
2,2-disubstituted glycerol and glycerol-like compounds, compositions and methods of use Grant 5,185,334 - Solomon , et al. February 9, 1	1993-02-09
Benzopyrido piperidine, piperidylidene and piperazine compounds, compositions, methods of manufacture and methods of use Grant 5,104,876 - Piwinski , et al. April 14, 1	1992-04-14
Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies Grant 5,089,496 - Piwinski , et al. February 18, 1	1992-02-18
Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof Grant 5,039,676 - Saksena , et al. August 13, 1	1991-08-13
Fused polycyclic pyranyl compounds as antiviral agents Grant 5,034,531 - Friary , et al. July 23, 1	1991-07-23
Processes for preparation of cyclopentyl purine derivatives Grant 5,015,739 - Saksena , et al. * May 14, 1	1991-05-14
Process for preparing cyclopentyl purine derivatives Grant 4,999,428 - Saksena , et al. March 12, 1	1991-03-12
3-O-glycosyl 16-membered macrolide antibacterials and related derivatives Grant 4,962,146 - Mallams , et al. October 9, 1	1990-10-09
Pharmaceutically active compounds Grant 4,851,423 - Girijavallabhan , et al. July 25, 1	1989-07-25
Antiallergic 6,11-dihydro-11-(4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridin es Grant 4,804,666 - Piwinski , et al. February 14, 1	1989-02-14
Processes for the production of penems Grant 4,530,793 - Girijavallabhan , et al. * July 23, 1	1985-07-23
Process for the production of antibiotic penems Grant 4,443,373 - Girijavallabhan , et al. April 17, 1	1984-04-17
23-Demycinosyltylosin compounds, pharmaceutical compositions and method of use Grant 4,436,729 - Ganguly , et al. March 13, 1	1984-03-13
Macrolide antibacterial AR-5 components Grant 4,373,095 - Ganguly , et al. February 8, 1	1983-02-08
Triazolo [4,5-d]-pyrimidines Grant 4,076,711 - Ganguly , et al. February 28, 1	1978-02-28
Preparation of 12,13-desepoxy-12,13-dehydrorosamicin Grant 3,975,372 - Ganguly , et al. August 17, 1	1976-08-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.